Boston Scientific Corp
BSXNYSECIK 885725HealthcareFiscal year ends Dec 31
Reports and events: 396 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-05-0616:13 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000885725-24-000048 |
| 2024-05-0116:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000885725-24-000046 |
| 2024-04-2406:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-24-000040 |
| 2024-04-0407:19 ET | 8-K | 8.01 Other events | 0000885725-24-000037 |
| 2024-03-2017:06 ET | DEF 14A | Proxy statementPeriod 2024-03-20 | 0000885725-24-000033 |
| 2024-02-2716:37 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-24-000025 |
| 2024-02-2116:47 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0000885725-24-000020 |
| 2024-02-2016:23 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000885725-24-000017 |
| 2024-01-3116:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000885725-24-000014 |
| 2024-01-3106:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-24-000011 |
| 2024-01-0817:17 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000885725-24-000007 |
| 2024-01-0807:06 ET | 8-K | 7.01 Regulation FD disclosure | 0000885725-24-000003 |
| 2023-11-2216:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885725-23-000051 |
| 2023-11-0116:04 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000885725-23-000048 |
| 2023-10-2606:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-23-000045 |
| 2023-08-0316:06 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000885725-23-000043 |
| 2023-07-2706:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-23-000041 |
| 2023-06-2716:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885725-23-000038 |
| 2023-06-0616:29 ET | 8-K | 8.01 Other events | 0000885725-23-000033 |
| 2023-05-0916:12 ET | 8-K | 5.07 Shareholder vote results | 0000885725-23-000028 |
| 2023-05-0416:07 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000885725-23-000026 |
| 2023-04-2606:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-23-000024 |
| 2023-03-2216:17 ET | DEF 14A | Proxy statementPeriod 2023-05-04 | 0000885725-23-000017 |
| 2023-03-0116:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-23-000010 |
| 2023-02-2316:20 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000885725-23-000008 |
| 2023-02-0106:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-23-000004 |
| 2023-01-3116:54 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-23-008661 |
| 2022-11-2116:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885725-22-000030 |
| 2022-11-0316:13 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000885725-22-000028 |
| 2022-10-2606:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-22-000026 |
| 2022-08-0416:16 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000885725-22-000023 |
| 2022-07-2706:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-22-000020 |
| 2022-05-0616:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-22-057017 |
| 2022-05-0516:11 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000885725-22-000013 |
| 2022-04-2706:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-22-000011 |
| 2022-04-0516:39 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000885725-22-000009 |
| 2022-03-2316:02 ET | DEF 14A | Proxy statementPeriod 2022-05-05 | 0001104659-22-037008 |
| 2022-03-1716:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-035047 |
| 2022-03-0817:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-031615 |
| 2022-03-0206:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-028937 |
| 2022-02-2316:34 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000885725-22-000006 |
| 2022-02-1516:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-22-000004 |
| 2022-02-0206:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-22-000002 |
| 2021-11-2316:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885725-21-000056 |
| 2021-11-0916:19 ET | 8-K | 8.01 Other events | 0000885725-21-000054 |
| 2021-11-0416:48 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000885725-21-000052 |
| 2021-10-2706:44 ET | 8-K | 2.02 Results of operations; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0000885725-21-000049 |
| 2021-10-0616:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-21-000045 |
| 2021-09-2116:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-21-000043 |
| 2021-09-0107:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-21-000039 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:38 ET. Listed shows no prices and gives no investment advice.